about
Age at childhood infections and risk of atopy.Prevalence of atopic dermatitis in infants by domestic water hardness and season of birth: Cohort study.Filaggrin genotype and skin diseases independent of atopic dermatitis in childhood.The role of filaggrin mutations during pregnancy and postpartum: atopic dermatitis and genital skin diseases.Common filaggrin gene mutations and risk of cervical cancer.Parvovirus B19 infection in pregnancy and subsequent morbidity and mortality in offspring.Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial.Measles and atopy--rash on rash?Major stressful life events in adulthood and risk of multiple sclerosis.Familial aggregation of tonsillectomy in early childhood and adolescence.Sibship characteristics and risk of multiple sclerosis: a nationwide cohort study in Denmark.Cesarean section and offspringʼs risk of inflammatory bowel disease: A national cohort studyAge at bacille Calmette-Guerin vaccination and risk of allergy and asthmaParvovirus B19 Infection in the First Trimester of Pregnancy and Risk of Fetal Loss: A Population-based Case-Control StudyTrichuris suisova therapy for allergic rhinitis does not affect allergen-specific cytokine responses despite a parasite-specific cytokine responseHelminth Infection Does Not Reduce Risk for Chronic Inflammatory Disease in a Population-Based Cohort StudyBirth by caesarean section and wheezing, asthma, allergy, and intestinal diseaseInteraction between filaggrin mutations and neonatal cat exposure in atopic dermatitisRetrospective markers of paediatric atopic dermatitis persistence after hospital diagnosis: A nationwide cohort study
P50
Q35535175-7E057579-E3B1-42E8-A220-9F782F7533D8Q39065401-B3540630-E127-4B19-B221-E33317E03DD1Q40289819-77599DCF-84CC-44E3-8F67-DDE946A0E7F8Q40808753-21E74432-9AAB-41F3-9758-AFCD9EFE097AQ41669695-19EBFA12-9FFD-4B16-A50B-53A7CB161E87Q42246767-FA6188BE-6218-47D9-A7EB-37263542C23FQ43267694-668E0BB4-3C4A-46CC-A6C5-027B676B54F2Q44474427-E1C13520-FE3C-48DD-A297-5C73E17929DFQ47906763-DBAA2CB5-CBCE-49C3-9713-F00100815A15Q49385571-5C80A070-2377-4A03-A86C-6344DFCFC226Q50543662-9E5FC9E8-E6D9-428A-B688-3307866E245BQ57422863-8F733FC4-2FED-4EDD-80B9-E57FE2B8411BQ57579893-EB6D4F14-451C-4B8E-8546-07762D4B1DF6Q58319967-D80ED2ED-35F1-464E-B547-57EB15326726Q58465074-B1CEBDC0-F9E8-44A9-9460-F3286FF90BAFQ63353095-294FDEE8-DB92-43D5-885F-6499DB6FD6B4Q83199366-134540FC-173C-4463-9C48-9D6E0D17441AQ92252602-6F3BD53A-2C1E-4A3D-B2AE-1B9207C25329Q92973727-33F674F4-13C9-4B84-8798-A11B1E56AF13
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter Bager
@ast
Peter Bager
@en
Peter Bager
@es
Peter Bager
@nl
type
label
Peter Bager
@ast
Peter Bager
@en
Peter Bager
@es
Peter Bager
@nl
prefLabel
Peter Bager
@ast
Peter Bager
@en
Peter Bager
@es
Peter Bager
@nl
P108
P106
P31
P496
0000-0002-3577-8459